Vol. 29, No. 1-2, 2007
Issue release date: November 2007
Free Access
link Erratum (7 KB)     
Neuroepidemiology 2007;29:125–132
(DOI:10.1159/000109998)
Original Paper
Add to my selection

Prevalence of Dementia in the United States: The Aging, Demographics, and Memory Study

Plassman B.L.a · Langa K.M.c, d, e · Fisher G.G.d · Heeringa S.G.d · Weir D.R.d · Ofstedal M.B.d · Burke J.R.b · Hurd M.D.f · Potter G.G.a · Rodgers W.L.d · Steffens D.C.a · Willis R.J.d · Wallace R.B.g
Departments of aPsychiatry and Behavioral Sciences, and bMedicine (Neurology), Duke University Medical Center, Durham, N.C., cDivision of General Medicine, Department of Medicine, and dInstitute for Social Research, University of Michigan, and eVeterans Affairs Center for Practice Management and Outcomes Research, Ann Arbor, Mich., fRAND, Santa Monica, Calif., and gColleges of Public Health and Medicine, University of Iowa, Iowa City, Iowa, USA
email Corresponding Author


 goto top of outline Key Words

  • Dementia
  • Aging
  • Epidemiology
  • Population-based research

 goto top of outline Abstract

Aim: To estimate the prevalence of Alzheimer’s disease (AD) and other dementias in the USA using a nationally representative sample. Methods: The Aging, Demographics, and Memory Study sample was composed of 856 individuals aged 71 years and older from the nationally representative Health and Retirement Study (HRS) who were evaluated for dementia using a comprehensive in-home assessment. An expert consensus panel used this information to assign a diagnosis of normal cognition, cognitive impairment but not demented, or dementia (and dementia subtype). Using sampling weights derived from the HRS, we estimated the national prevalence of dementia, AD and vascular dementia by age and gender. Results: The prevalence of dementia among individuals aged 71 and older was 13.9%, comprising about 3.4 million individuals in the USA in 2002. The corresponding values for AD were 9.7% and 2.4 million individuals. Dementia prevalence increased with age, from 5.0% of those aged 71–79 years to 37.4% of those aged 90 and older. Conclusions: Dementia prevalence estimates from this first nationally representative population-based study of dementia in the USA to include subjects from all regions of the country can provide essential information for effective planning for the impending healthcare needs of the large and increasing number of individuals at risk for dementia as our population ages.

Copyright © 2007 S. Karger AG, Basel


 goto top of outline References
  1. Federal Interagency Forum on Aging Related Statistics: Older Americans 2004: Key Indicators of Well-Being. http://www.agingstats.gov/chartbook2004/population.html (accessed June 28, 2007).
  2. Brookmeyer R, Gray S, Kawas S: Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset. Am J Publ Health 1998;88:1337–1342.
  3. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M: Global prevalence of dementia: a Delphi consensus study. Lancet 2005;366:2112–2117.
  4. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA: Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 2003;60:1119–1122.
  5. Evans DA, Scherr PA, Cook NR, Albert MS, Funkenstein HH, Smith LA, Hebert LE, Wetle TT, Branch LG, Chown M, Hennekens CH, Taylor JO: Estimated prevalence of Alzheimer’s disease in the United States. Milbank Q 1990;68:267–289.
  6. United States General Accounting Office: Alzheimer’s Disease: Estimates of Prevalence in the United States. Washington, United States General Accounting Office, 1998.
  7. Obisesan TO, Vargas CM, Gillum RF: Geographic variation in stroke risk in the United States: region, urbanization, and hypertension in the Third National Health and Nutrition Examination Survey. Stroke 2000;31:19–25.
  8. Center for Disease Control: Regional and racial differences in prevalence of stroke – 23 states and the District of Columbia, 2003. http://www.cdc.gov/mmwR/preview/mmwrhtml/mm5419a3.htm (accessed February 2, 2007).
  9. Juster FT, Suzman R: An overview of the Health and Retirement Study. J Hum Resources 1995;30(suppl):135–145.
  10. Willis RJ: Theory confronts data: how the HRS is shaped by the economics of aging and how the economics of aging will be shaped by the HRS. Labour Econ 1999;6:119–145.

    External Resources

  11. Soldo BJ, Hurd MD, Rodgers WL, Wallace RB: Asset and health dynamics among the oldest old: an overview of the AHEAD study. J Gerontol Ser B Psychol Sci Soc Sci 1997;52B:1–20.
  12. Ofstedal MB, Fisher G, Herzog AR: Documentation of cognitive functioning measures in the Health and Retirement Study. http://hrsonline.isr.umich.edu/docs/userg/dr-006.pdf (accessed February 15, 2007).
  13. Heeringa SG, Fisher GG, Hurd MD, Langa KM, Ofstedal MB, Plassman BL, Rodgers W, Weir DR: Aging, Demographics and Memory Studys (ADAMS). Sample design, weights, and analysis for ADAMS. http://hrsonline.isr.umich.edu/meta/adams/desc/AdamsSampleWeights.pdf. Accessed on September 24, 2007.
  14. Langa KM, Plassman BL, Wallace RB, Herzog AR, Heeringa SG, Ofstedal MB, Burke JR, Fisher GG, Fultz NH, Hurd MD, Potter GG, Rodgers WL, Steffens DC, Willis RJ: The Aging, Demographics, and Memory Study: study design and methods. Neuroepidemiology 2005;25:181–191.
  15. Little RJA, Rubin DB: Statistical Analysis with Missing Data, ed 2. New York, Wiley & Sons, 2002.
  16. The Health and Retirement Study. http:// hrsonline.isr.umich.edu/ (accessed February 15, 2007).
  17. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 3, revised. Washington, American Psychiatric Association, 1987.
  18. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
  19. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, Moody DM, O’Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Scheinberg P: Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250–260.
  20. Lund and Manchester Groups: Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994;57:416–418.
  21. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Ewardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen ENH, Ballard C, de Vos RAI, Wilcock GK, Jellinger KA, Perry RH: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113–1124.
  22. Plassman BL, Khachaturian AS, Townsend JJ, Ball MJ, Steffens DC, Leslie CE, Tschanz JT, Norton MC, Burke JR, Welsh-Bohmer KA, Hulette CM, Nixon RR, Tyrey M, Breitner JCS: Comparison of clinical and neuropathological diagnoses of AD in three epidemiological samples. Alzheimer’s Dement 2006;2:2–11.
  23. US Census Bureau: Table 1: Annual estimates of the population by five-year age groups and sex for the United States: April 1, 2000 to July 1, 2006. http://www.census.gov/popest/national/asrh/NC-EST2006-sa.html. Accessed on October 19, 2007.
  24. Bureau of Labor Statistics and the Bureau of the Census: Current population survey. http://www.bls.census.gov/cps/cpsmain.htm (accessed June 28, 2007).
  25. Hofman A, Rocca WA, Brayne C, Breteler MMB, Clarke M, Cooper B, Copeland JRM, Dartigues JF, da Silva Droux A, Hagnell O, Heeren TJ, Engedal K, Jonker C, Lindesay J, Lobo A, Mann AH, Molsa PK, Morgan K, O’Connor DW, Sulkava R, Kay DWK, Amaducci L: The prevalence of dementia in Europe: a collaborative study of 1980–1990 findings. Int J Epidemiol 1991;20:736–748.
  26. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA: Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 2003;60:1119–1122.
  27. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task force on Alzheimer’s disease. Neurology 1984;34:939–944.
  28. Graham JE, Rockwood K, Beattie BL, Eastwood R, Gauthier S, Tuokko H, McDowell I: Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997;349:1793–1796.
  29. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303–308.
  30. Breitner JCS, Wyse BW, Anthony JC, Welsh-Bohmer KA, Steffens DC, Norton MC, Tschanz JT, Plassman BL, Meyer MR, Skoog I, Khachaturian A: APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. Neurology 1999;53:321–331.
  31. Hendrie H, Osuntokun B, Hall K, Ogunniyi A, Hui S, Unverzagt F, Gureje O, Rodenberg C, Baiyewu O, Musick B, Adeyinka A, Farlow M, Oluwole S, Class C, Komolafe O, Brashear A, Burdine V: Prevalence of Alzheimer’s disease and dementia in two communities: Nigerian Africans and African Americans. Am J Psychiatry 1995;152:1485–1492.
  32. Breteler MMB, Claus JJ, van Duijn CM, Launer LJ, Hofman A: Epidemiology of Alzheimer’s disease. Epidemiol Rev 1992;14:59–82.
  33. Jorm AF, Korten AE, Henderson AS: The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 1987;76:465–479.
  34. Canadian Study of Health and Aging Working Group: Canadian Study of Health and Aging: study methods and prevalence of dementia. Can Med Assoc J 1994;150:899–913.
  35. Katzman R: Education and the prevalence of dementia and Alzheimer’s disease. Neurology 1993;43:12–20.

    External Resources

  36. Friedland RP: Epidemiology, education, and the ecology of Alzheimer’s disease. Neurology 1993;43:246–249.
  37. Beard CM, Kokmen E, Offord KP, Kurland LT: Lack of association between Alzheimer’s disease and education, occupation, marital status, or living arrangement. Neurology 1992;42:2063–2068.
  38. Bachman DL, Wolf PA, Linn R, Knoefel JE, Cobb J, Belanger A, D’Agostino RB, White LR: Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology 1992;42:115–119.
  39. Launer LJ, Andersen K, Dewey ME, Letenneur L, Ott A, Amaducci LA, Brayne C, Copeland JRM, Dartigues J-F, Kragh-Sorensen P, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A, EURODEM Incidence Research Group and Work Groups: Rates and risk factors for dementia and Alzheimer’s disease. Neurology 1999;52:78–84.
  40. Hebert LE, Scherr PA, McCann JJ, Beckett LA, Evans DA: Is the risk of developing Alzheimer’s disease greater for women than for men? Am J Epidemiol 2001;153:132–136.
  41. Paykel ES, Brayne C, Huppert FA, Gill C, Barkley C, Gehlhaar E, Beardsall L, Girling DM, Pollitt P, O’Connor D: Incidence of dementia in a population older than 75 years in the United Kingdom. Arch Gen Psychiatry 1994;51:325–332.
  42. Tang MX, Cross P, Andrews H, Jacobs DM, Small S, Bell K, Merchant C, Lantigua R, Costa R, Stern Y, Mayeux R: Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology 2001;56:49–56.
  43. Perkins P, Annegers JF, Doody RS, Cooke N, Aday L, Vernon SW: Incidence and prevalence of dementia in a multiethnic cohort of municipal retirees. Neurology 1997;49:44–50.
  44. Fillenbaum GG, Heyman A, Huber MS, Woodbury MA, Schmader KE, Bohannon A, Trapp-Moen B: The prevalence and 3-year incidence of dementia in older Black and White community residents. J Clin Epidemiol 1998;51:587–595.
  45. Fitzpatrick AL, Kuller LH, Ives DG, Lopez OL, Jagust W, Breitner JCS, Jones B, Lyketsos C, Dulberg C: Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc 2004;52:195–204.
  46. Evans DA, Bennett DA, Wilson RS, Bienias JL, Morris MC, Scherr PA, Hebert LE, Aggarwal N, Beckett LA, Joglekar R, Berry-Kravis E, Schneider J: Incidence of Alzheimer disease in a biracial urban community. Arch Neurol 2003;60:185–189.
  47. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM: Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA 1997;278:1349–1356.
  48. Tell GS, Fried LP, Hermanson B, Manolio TA, Newman AB, Borhani NO: Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. Ann Epidemiol 1993;3:358–366.
  49. Sloane PD, Zimmerman S, Suchindran C, Reed P, Wang L, Boustani M, Sudha S: The public health impact of Alzheimer’s disease, 2000–2050: potential implication of treatment advances. Annu Rev Publ Health 2002;23:213–231.

 goto top of outline Author Contacts

Brenda Plassman, PhD
905 W. Main Street, Ste 25-D, Box 41
Duke University Medical Center
Durham, NC 27701 (USA)
Tel. +1 919 682 6722, Fax +1 919 687 0424, E-Mail brenda.plassman@duke.edu


 goto top of outline Article Information

Published online: October 29, 2007
Number of Print Pages : 8
Number of Figures : 0, Number of Tables : 5, Number of References : 49


 goto top of outline Publication Details

Neuroepidemiology

Vol. 29, No. 1-2, Year 2007 (Cover Date: November 2007)

Journal Editor: Román, G.C. (San Antonio, Tex.)
ISSN: 0251–5350 (Print), eISSN: 1423–0208 (Online)

For additional information: http://www.karger.com/NED


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.